Abstract
Canada’s National Advisory Committee on Immunization (NACI) makes recommendations on the use of human vaccines. Traditionally, NACI reviewed vaccine characteristics and disease burden. With its expanded mandate, NACI now considers cost-effectiveness via economic evaluations; thus, warranting guidelines. Existing guidelines are either not specific to the universal healthcare context, or not specific to vaccination programs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
